Join our Community
Support ToI and remove all ads
Learn more

ISRAEL AT WAR - DAY 427

Gilad Alper

Zehut party number two Rabbi Haim Amsalem speaking to potential voters in Safed, March 9, 2019. (David Cohen/Flash90)
March 17, 2019, 1:39 pm
Ex-Shas MK, economist, anti-vaxxer: Who’s on Feiglin’s pro-cannabis Zehut list?
Array of candidates are united not by support of marijuana legalization but by a rejection of mainstream opinions and an embrace of issues on the political fringes
By Raoul Wootliff
A general view of TEVA Pharmaceutical Industries in Jerusalem, Israel, October 11, 2013. (Yonatan Sindel/Flash90)
June 11, 2017, 5:53 pm
Teva shares rise in Tel Aviv as migraine results buoy investors
Drug is expected to lessen headache for pharma firm, which is facing stiff competition for its flagship anti-MS treatment Copaxone
By Shoshanna Solomon
A general view of TEVA Pharmaceutical Industries in Jerusalem, Israel, October 11, 2013. (Yonatan Sindel/Flash90)
January 26, 2017, 2:08 pm
Suffering from missteps, drugmaker Teva struggles to heal own ills
A constant fixture of Israelis’ saving plans, pharma firm’s shares have plummeted as its CEO embarked on aggressive acquisition adventures, wiping billions from portfolios
By Shoshanna Solomon
An Israeli Air Force drone, Hermes 450 UAV, manufactured by Elbit (photo credit: Elbit via Tsahi Ben-Ami/Flash 90)
July 10, 2016, 1:13 pm
Elbit sets up energy unit with international investor
New company will develop energy solutions for civilian transportation applications, Elbit says
By Shoshanna Solomon
Load More
Sign in or Register
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.